(XLV) Health Care Sector Fund - Overview

ETF Category: Health | Exchange: NYSE ARCA (USA) | Market Cap: 37.188m USD | Total Return: 16.1% in 12m

Pharmaceuticals, Medical Equipment, Biotechnology, Health Services
Total Rating 51
Safety 63
Buy Signal -0.48
Health
Category Rotation: +12.5
TER: 0.09%
AUM: 37.2B
Avg Turnover: 1.52B
Risk 3d forecast
Volatility15.1%
VaR 5th Pctl2.65%
VaR vs Median-2.67%
Reward TTM
Sharpe Ratio0.84
Rel. Str. IBD43.8
Rel. Str. Peer Group33.3
Character TTM
Beta0.317
Beta Downside0.342
Hurst Exponent0.478
Drawdowns 3y
Max DD17.11%
CAGR/Max DD0.43
CAGR/Mean DD1.40

Warnings

Extended 3d

Tailwinds

No distinct edge detected

Description: XLV Health Care Sector Fund

The Health Care Select Sector SPDR Fund (XLV) utilizes a replication strategy to track the performance of the Health Care Select Sector Index. The fund maintains a concentrated portfolio, investing at least 95% of its total assets in equity securities spanning pharmaceuticals, biotechnology, and healthcare equipment providers.

The healthcare sector is characterized by high research and development (R&D) costs and extensive regulatory oversight, which often creates significant barriers to entry for new competitors. Many constituent companies operate under a defensive business model, as demand for medical services and life sciences tools remains relatively inelastic regardless of broader economic cycles.

Investors can further evaluate the underlying fundamentals of these holdings by visiting ValueRay. Because the fund is classified as non-diversified, it may concentrate its assets in a smaller number of individual issuers compared to broad-market indices.

Headlines to Watch Out For
  • Medicare reimbursement rate adjustments impact profitability for major health care providers
  • FDA drug approval cycles and patent expirations drive pharmaceutical revenue volatility
  • Consolidation in health insurance sector influences managed care margins and pricing
  • Research and development spending levels dictate growth for biotechnology and life sciences
  • Federal legislative changes to drug pricing affect long-term pharmaceutical sector earnings
What is the price of XLV shares?

As of June 08, 2026, the stock is trading at USD 153.01 with a total of 20,708,019 shares traded.
Over the past week, the price has changed by +2.37%, over one month by +5.73%, over three months by -0.40% and over the past year by +16.09%.

Is XLV a buy, sell or hold?

Health Care Sector Fund has no consensus analysts rating.